/

Società

Po

Non verificato

PopVax

Di cosa scriviamo

EventiFarmaceuticaHIV, AIDS e malattie autoimmuniIndustriaSalute

3 comunicati stampa

Guarda tutti i comunicati

13/01/2025

Eventi

Fiere

Industria

HIV, AIDS e malattie autoimmuni

Farmaceutica

Salute

Medicina - Varie

PopVax is Awarded 2 Million USD as One of the Winners of the BARDA Patch Forward Prize for its Seasonal Influenza Vaccine built on a Novel mRNA-encoded Immunogen Display Architecture Delivered via Dissolvable Microarray Patch

Fonte

Emittente

1.00

0

13/11/2024

Salute

Sanità

Scienza

Farmaceutica

Eventi

Industria

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen

Fonte

Emittente

1.00

0

30/10/2024

Volontariato/Solidarietà/Non profit

Industria

Mercato del lavoro

Analisi di mercato

Associazioni/Professionisti

Scienza

Farmaceutica

HIV, AIDS e malattie autoimmuni

Biotecnologia

Medicina - Varie

Sanità

Comunicazione

Salute

PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0